US2018185477A1PendingUtilityA1

Qsox1 as an anti-neoplastic drug target

66
Assignee: YEDA RES & DEVPriority: Sep 20, 2010Filed: Feb 19, 2018Published: Jul 5, 2018
Est. expirySep 20, 2030(~4.2 yrs left)· nominal 20-yr term from priority
G01N 33/5011C12Y 108/03002C12Q 2600/118C12N 15/1137A61K 39/3955C12Q 1/6886C12Q 2600/158C12N 15/1135G01N 33/5008A61K 38/44C12N 2310/531C12N 2320/30C12Q 1/26C07K 16/40C12N 2310/14A61K 39/39558C12N 2310/11A61K 2121/00
66
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides methods for tumor treatment by administering an inhibitor of quiescin sulfhydryl oxidase 1 (QSOX1), compositions comprising such inhibitors, and methods for identifying such inhibitors.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method for tumor treatment, comprising administering to a subject having a tumor an amount effective of an anti quiescin sulfhydryl oxidase 1 (QSOX1) antibody, or a pharmaceutically acceptable salt thereof, to treat the tumor, wherein the tumor is a pancreatic tumor that over-expresses QSOX1 compared to control. 
     
     
         2 . A method for pancreatic tumor treatment, comprising administering to a subject having a pancreatic tumor an amount effective of an anti quiescin sulfhydryl oxidase 1 (QSOX1) antibody, or a pharmaceutically acceptable salt thereof, to treat the pancreatic tumor. 
     
     
         3 . The method of  claim 2 , wherein the pancreatic tumor comprises a pancreatic adenocarcinoma. 
     
     
         4 . A method for breast tumor treatment, comprising administering to a subject having a breast tumor an amount effective of an anti quiescin sulfhydryl oxidase 1 (QSOX1) antibody, or a pharmaceutically acceptable salt thereof, to treat the breast tumor. 
     
     
         5 . The method of  claim 4 , wherein the tumor is an estrogen receptor positive (ER+) breast tumor. 
     
     
         6 . The method of  claim 4 , wherein the breast tumor is a Luminal B breast tumor. 
     
     
         7 . The method of  claim 2 , wherein the method limits tumor metastasis. 
     
     
         8 . A method inhibiting tumor metastasis, comprising administering to a subject having a breast tumor an amount effective of an anti quiescin sulfhydryl oxidase 1 (QSOX1) antibody, or a pharmaceutically acceptable salt thereof, to inhibit metastasis of the breast tumor. 
     
     
         9 . The method of  claim 8 , wherein the tumor is a cytokeratin 5/6 negative breast tumor, or a Luminal B breast tumor. 
     
     
         10 . A method inhibiting tumor metastasis, comprising administering to a subject having a pancreatic tumor an amount effective of an anti quiescin sulfhydryl oxidase 1 (QSOX1) antibody, or a pharmaceutically acceptable salt thereof, to inhibit metastasis of the pancreatic tumor.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.